-
Moderna initiates Phase III trial of COVID-19 vaccine candidate
europeanpharmaceuticalreview
August 04, 2020
The first patients have been dosed in Moderna’s Phase III clinical trial of its mRNA vaccine candidate to protect against COVID-19.
-
UK to roll out COVID-19 diagnostic that provides results in under two hours
europeanpharmaceuticalreview
August 04, 2020
An initial 450,000 of Oxford Nanopore’s LamPORE test will be used by the UK government as COVID-19 diagnostics, which yield results in under two hours.
-
Sanofi and GSK Selected for Operation Warp Speed
contractpharma
August 04, 2020
To supply U.S. government with 100 million doses of COVID-19 vaccine in $2.1 billion deal.
-
Altimmune and CDMO Vigene Enter COVID-19 Vax Pact
contractpharma
August 04, 2020
Ink manufacturing agreement for AdCOVID single dose intranasal vaccine candidate.
-
HDMA sets up two COVID-19 quarantine centres
expresspharma
August 04, 2020
The new quarantine centres have over 250 beds dedicated to the members of the association.
-
Jubilant Life Sciences launches JUBI-R for COVID-19 treatment
expresspharma
August 04, 2020
The company will make the drug available to over 1,000 hospitals providing COVID-19 treatment in India through its distribution network.
-
Study reveals macular degeneration can intensify severity of COVID-19
expresspharma
August 04, 2020
Existing drugs that inhibit the complement system could help treat patients with severe disease.
-
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment
expresspharma
August 04, 2020
I-SPY COVID will evaluate the impact of cenicriviroc, Otezla, and Firazyr on inflammatory response in severely ill, hospitalised COVID-19 patients.
-
Vopec Pharma completes COVID-19 clinical trials of herbal formulation, Amrta Karuna
expresspharma
August 04, 2020
Vopec Pharmaceuticals has announced that it has completed COVID-19 clinical trials on a herbal, Siddha formulation, Amrta Karuna.
-
US invests over $240 million into seven new COVID-19 diagnostic tests
europeanpharmaceuticalreview
August 03, 2020
The National Institutes of Health in the US has awarded contracts to seven biomedical companies to develop and manufacture COVID-19 diagnostics.